Related by context. All words. (Click for frequent words.) 75 recurrent ovarian cancer 75 trabectedin 74 taxane chemotherapy 73 Doxil ® 73 Herceptin trastuzumab 73 gemcitabine Gemzar 73 Pemetrexed 72 pegylated liposomal doxorubicin 72 resistant ovarian cancer 72 sorafenib Nexavar 72 metastatic renal cell carcinoma 72 docetaxel chemotherapy 72 bevacizumab Avastin 72 paclitaxel carboplatin 72 Irinotecan 71 paclitaxel Taxol 71 prostate cancer CRPC 71 bevacizumab Avastin ® 71 pomalidomide 71 alkylating agent 71 gastrointestinal stromal tumors 71 MAGE A3 ASCI 71 mycophenolate mofetil 70 prostate cancer HRPC 70 aromatase inhibitors AIs 70 liposomal doxorubicin 70 invasive candidiasis 70 trastuzumab Herceptin ® 70 Erlotinib 70 dasatinib Sprycel 70 taxane therapy 70 docetaxel Taxotere 70 Gleevec imatinib 70 sunitinib malate 70 lapatinib Tykerb 70 idarubicin 70 5FU 70 recurrent glioblastoma multiforme 70 Velcade bortezomib 70 Gleevec resistant 70 Dasatinib 70 platinum refractory 70 standard chemotherapy regimens 70 gastrointestinal stromal tumors GIST 70 anti angiogenic agents 70 TEMODAL 70 paclitaxel Taxol R 70 YONDELIS 70 DFMO 70 LHRH receptor positive 69 HER2 positive metastatic breast 69 imatinib Gleevec 69 GnRH agonists 69 erlotinib Tarceva ® 69 refractory ovarian cancer 69 recurrent ovarian 69 bendamustine 69 cytostatic 69 urothelial bladder cancer 69 adriamycin 69 lenalidomide dexamethasone 69 relapsed MM 69 vandetanib 69 Adjuvant chemotherapy 69 microwave hyperthermia 69 fallopian tube carcinoma 69 nab paclitaxel 69 Taxotere chemotherapy 69 pertuzumab 69 iniparib 69 basal cell carcinoma BCC 69 rituximab Rituxan 69 Cisplatin 69 mRCC 69 Vidaza azacitidine 69 ixabepilone 69 antiangiogenic therapy 69 EGFR tyrosine kinase inhibitors 69 mTOR inhibitors 69 superficial bladder cancer 69 estramustine 69 Hycamtin 69 Paraplatin ® 69 Revlimid lenalidomide 69 Natalizumab 68 Aplidin 68 refractory metastatic colorectal cancer 68 lupus nephritis 68 cilengitide 68 platelet inhibitor 68 ritonavir boosted 68 chemotherapy cisplatin 68 cisplatin chemotherapy 68 gemcitabine carboplatin 68 CHOP chemotherapy 68 cytotoxic therapy 68 noninfectious uveitis 68 malignant pleural mesothelioma 68 Paraplatin ® carboplatin 68 ZOLINZA 68 thalidomide Thalomid 68 Zolinza 68 chemotherapy docetaxel 68 topotecan 68 metastatic RCC 68 erlotinib Tarceva 68 cytotoxic chemotherapy 68 bortezomib Velcade 68 standard chemotherapy regimen 68 malignant ascites 68 Rituxan rituximab 68 goserelin 68 APTIVUS r 68 recurrent NSCLC 68 Platinol ® cisplatin 68 Taxotere docetaxel 68 vinorelbine 68 azacitidine 68 uric acid lowering 68 Amrubicin 68 metastatic malignant 68 chemopreventive agent 68 Taxotere ® 68 Ceflatonin 68 oblimersen 68 metastatic malignant melanoma 68 EndoTAGTM 1 68 chlorambucil 68 overlapping toxicities 68 androgen independent 68 cinacalcet 68 meropenem 68 dacarbazine 68 operable breast cancer 68 Sanofi Aventis Taxotere 68 recurrent glioblastoma 68 neratinib 68 LHRH agonists 68 Faslodex 68 chemoradiotherapy 68 metaglidasen 68 evaluating tivozanib 68 cetuximab Erbitux ® 68 refractory colorectal cancer 68 metastatic bladder 68 anticancer therapy 67 axitinib 67 temsirolimus 67 Nexavar sorafenib 67 Virulizin ® 67 benign prostatic hypertrophy 67 abiraterone 67 Fludarabine 67 sorafenib tablets 67 Gleevec imatinib mesylate 67 gemcitabine cisplatin 67 decitabine 67 pegylated interferon alfa 67 metastatic castration resistant 67 Bezielle 67 Oxaliplatin 67 temozolomide 67 radiation sensitizer 67 cediranib 67 flutamide 67 antimetabolite 67 receptor tyrosine kinase inhibitor 67 mapatumumab 67 metastatic hormone refractory 67 metastatic kidney 67 chemotherapeutic drug 67 carboplatin paclitaxel 67 HRPC 67 vorinostat 67 chronic lymphocytic leukemia CLL 67 Gefitinib 67 interferon alfa 67 olaparib 67 Avastin bevacizumab 67 heavily pretreated patients 67 nucleoside analog 67 paclitaxel Taxol ® 67 allogeneic HSCT 67 Arranon 67 IV bisphosphonates 67 efalizumab 67 capecitabine Xeloda 67 imatinib Gleevec ® 67 Combination therapy 67 trastuzumab Herceptin 67 HuMax EGFr 67 VEGF inhibitors 67 Panzem R NCD 67 Cytoxan 67 corticosteroid dexamethasone 67 Gemcitabine 67 pegylated interferons 67 docetaxel Taxotere ® 67 K ras mutations 67 Torisel 67 Egrifta 67 anti angiogenic therapy 67 colorectal liver metastases 67 riociguat 67 taxane refractory 67 palifermin 67 anthracycline taxane 67 interferon ribavirin 67 GW# [003] 67 Tavocept 67 ACZ# 67 cetuximab Erbitux 67 leukemia AML 67 relapsing multiple sclerosis 67 Noxafil 67 tipranavir 67 ganetespib 67 Temsirolimus 67 SCCHN 67 refractory CLL 67 proteasome inhibitor 67 Pertuzumab 67 Caelyx 67 vinca alkaloid 67 hormonal therapies 67 neoadjuvant 67 Degarelix 67 FUSILEV enhances 67 gefitinib Iressa 67 anti EGFR antibody 67 amrubicin 67 chemotherapeutic agent 67 antiresorptive 67 pegylated interferon alpha 67 refractory multiple myeloma 67 trastuzumab DM1 67 androgen ablation 67 adjuvant radiotherapy 67 gemcitabine chemotherapy 67 nucleoside analogues 67 cetuximab 67 relapsed SCLC 67 Roche Xeloda 67 CIMZIA ™ 67 liposomal formulation 67 recurrent GBM 67 Interferon alpha 67 Cloretazine 67 bicalutamide 67 fluoropyrimidine 66 cyclophosphamide methotrexate 66 Taxol paclitaxel 66 pharmacokinetic interactions 66 nucleoside analogs 66 CA4P 66 HER2 positive breast cancer 66 Tarceva erlotinib 66 dasatinib Sprycel ® 66 MyVax R 66 irinotecan oxaliplatin 66 anti androgen 66 Nilotinib 66 Panitumumab 66 Surgical resection 66 oral deforolimus 66 lenalidomide Revlimid R 66 neoadjuvant therapy 66 antiandrogen 66 postoperative chemotherapy 66 Ophena TM 66 Lenalidomide 66 chemo radiotherapy 66 fulvestrant 66 endocrine therapies 66 EGFR inhibitors 66 5-FU/LV 66 intravenous cyclophosphamide 66 boosted protease inhibitor 66 neoadjuvant treatment 66 Pegylated Interferon 66 sorafenib Nexavar ® 66 alvespimycin 66 Cetuximab 66 pegfilgrastim 66 intravenous bisphosphonates 66 tocilizumab 66 Peginterferon alfa 2b 66 surgical debulking 66 Vidaza ® 66 HuMax CD4 66 biliary tract cancer 66 Pfizer Sutent 66 Bortezomib 66 farletuzumab 66 BRAF inhibitor 66 MGd 66 nonsmall cell lung cancer 66 refractory metastatic 66 heavily pretreated 66 antitumor effect 66 castrate resistant 66 basiliximab 66 anti leukemic 66 OZURDEX ® 66 BAY #-# 66 CYT# potent vascular disrupting 66 tanespimycin 66 Proxinium TM 66 Aviptadil 66 androgen deprivation 66 trastuzumab 66 ZACTIMA 66 relapsing remitting MS RRMS 66 Sorafenib 66 irinotecan chemotherapy 66 Femara letrozole 66 albumin bound paclitaxel 66 mTOR inhibition 66 adjuvant radiation 66 HSP# inhibitor 66 Tyrima 66 prostate carcinoma 66 bone metastases 66 cardiotoxic 66 metastatic gastric 66 temozolomide TMZ 66 oxaliplatin Eloxatin 66 leukemia CLL 66 Annamycin 66 erythropoietic 66 mTOR inhibitor 66 endometrial hyperplasia 66 Fludara 66 GnRH antagonist 66 FOLFIRI 66 Halaven 66 chemoradiation therapy 66 Trastuzumab 66 anthracycline chemotherapy 66 chemoresistant 66 pain palliation 66 Golimumab 66 etoposide 66 lapatinib 66 Targretin 66 canakinumab 66 mitoxantrone plus 66 nucleoside analogue 66 chemotherapeutic agents 66 Platinol 66 pazopanib 66 BRAF inhibitors 66 Bevacizumab 66 palliative radiotherapy 66 cabazitaxel 66 metastatic colorectal 66 dasatinib 66 Dacogen decitabine 66 LHRH analogues 66 posaconazole 66 Navelbine ® 66 docetaxel 66 refractory myeloma 66 metastatic HRPC 66 demonstrated antitumor activity 66 prostate cancer AIPC 66 SIR Spheres 66 castrate resistant prostate cancer 65 TACE 65 Toxicities 65 relapsed refractory 65 seminoma 65 infusional 65 sunitinib 65 Azacitidine 65 myeloablative 65 recurrent metastatic 65 calcineurin inhibitor 65 5 Fluorouracil 65 OHR/AVR# 65 ovarian carcinoma 65 HuLuc# 65 GnRH agonist 65 TTF Therapy 65 epithelial ovarian cancer 65 relapsing MS 65 Topotecan 65 Yondelis 65 Neulasta ® 65 tigecycline 65 adjuvant cisplatin 65 β blockers 65 relapsed AML 65 DOXIL 65 luteinizing hormone releasing 65 docetaxel prednisone 65 metastatic colorectal carcinoma 65 tyrosine kinase inhibitor 65 Traficet EN 65 debulking surgery 65 Helicobacter pylori eradication 65 acute GvHD 65 Camptosar ® 65 bone metastasis 65 FOLFOX6 65 pancreatic neuroendocrine tumors 65 candidemia 65 gemcitabine Gemzar ® 65 Vandetanib 65 AEG# 65 dexrazoxane 65 velafermin 65 adalimumab Humira 65 potentially hepatotoxic 65 depsipeptide 65 HER2 overexpression 65 tamoxifen Nolvadex ® 65 Neoadjuvant 65 Ophena 65 esophageal candidiasis 65 refractory AML 65 histologies 65 aflibercept 65 cytoreduction 65 CANCIDAS 65 taxotere 65 pancreatic NET 65 nonmetastatic 65 Fulvestrant 65 refractory prostate cancer 65 TORISEL 65 FSAD 65 durable remissions 65 cisplatin gemcitabine 65 prostate cancer CaP 65 nonmelanoma skin cancers 65 antiandrogens 65 protease inhibitor PI 65 Ixempra 65 zoledronic acid Zometa 65 bevacizumab 65 secondary hyperparathyroidism 65 galiximab 65 SNT MC# 65 Xeloda capecitabine 65 paricalcitol 65 chronic HCV 65 aromatase inhibitor therapy 65 SERMs 65 NATRECOR ® 65 cetuximab Erbitux R 65 melphalan prednisone 65 Zarnestra 65 chemotherapeutic 65 OvaRex ® MAb 65 Aflibercept 65 relapsed multiple myeloma 65 interferon alfa 2b 65 oral clodronate 65 IMA# 65 epirubicin 65 immunomodulatory therapy 65 Mitomycin C 65 advanced hepatocellular carcinoma 65 peritoneal carcinomatosis 65 abacavir lamivudine 65 Mitoxantrone 65 regorafenib 65 pediatric malignancies 65 flavopiridol 65 systemic antifungal 65 chemotherapeutic regimens 65 ALA PDT 65 infusional 5-FU/LV 65 relapsed ALL 65 enzastaurin 65 paclitaxel poliglumex 65 Abacavir 65 teriflunomide 65 immunomodulator 65 caspofungin 65 anti CD3 antibody 65 Mepact 65 epirubicin cyclophosphamide 65 PegIFN RBV 65 external beam radiotherapy 65 Campath alemtuzumab 65 brain metastases 65 OncoVEX GM CSF 65 temozolomide Temodar 65 locoregional recurrence 65 DACH platinum 65 conventional DMARDs 65 concurrent chemoradiation 65 therapeutic regimens 65 Abiraterone 65 humanised monoclonal antibody 65 clodronate 65 adecatumumab 65 BZL# 65 liposomal amphotericin B 65 alkylating agents 65 colorectal carcinoma 65 Doxil 65 antiplatelet agent 65 TELINTRA 65 Riluzole 65 LY# [003] 65 PKC# 65 abiraterone acetate 65 seliciclib 65 TroVax ® 65 FOLFIRINOX 65 Certolizumab pegol 65 ribavirin RBV 65 clinically localized prostate 65 letrozole Femara 65 pediatric acute lymphoblastic 65 Glivec imatinib 65 PegIntron 65 Lapatinib 65 gastrointestinal stromal tumor GIST 65 stage IIIB 65 Onrigin 65 KRAS mutant tumors 64 BEACOPP 64 hormone refractory metastatic prostate 64 verteporfin 64 malignant lymphomas 64 oral mTOR inhibitor 64 AKT inhibitor 64 CCR5 inhibitor 64 vismodegib 64 ErbB2 positive 64 Dapagliflozin 64 cyclophosphamide chemotherapy 64 Darusentan 64 squamous cell lung cancer 64 interferon therapy 64 tipifarnib 64 papillary renal cell carcinoma 64 small molecule tyrosine 64 Tasigna nilotinib 64 sipuleucel T 64 demethylating agent 64 trans retinoic acid 64 Xanafide 64 ELACYT 64 5 FU leucovorin 64 transplantation HCT 64 docetaxel Taxotere R 64 raltegravir 64 Laquinimod 64 angiogenesis inhibition 64 VAPRISOL 64 serous ovarian cancer 64 amifostine 64 Tarceva TM 64 relapsing remitting multiple sclerosis 64 prednisone prednisolone 64 endometrial carcinoma 64 adjuvant therapy 64 proteasome inhibitor bortezomib 64 AZT zidovudine Retrovir 64 azacytidine 64 forodesine 64 recurrent genital herpes 64 pCR 64 Elotuzumab 64 Fluorouracil 64 Carboplatin 64 KRN# 64 miglustat 64 metastatic neuroendocrine tumors 64 invasive lobular carcinoma 64 FOLFOX4 64 panitumumab Vectibix 64 Erbitux cetuximab 64 DOXIL ® 64 SUTENT ® 64 Torisel temsirolimus 64 BRCA deficient 64 tiuxetan 64 Fludara ® 64 aflibercept VEGF Trap 64 XELOX 64 TREANDA 64 EVIZON 64 Hepatocellular Carcinoma HCC 64 zoledronic acid 64 etanercept Enbrel 64 breast carcinoma 64 PROCHYMAL 64 Docetaxel 64 anthracyclines taxanes 64 biologic therapy 64 herpetic keratitis 64 superficial basal cell carcinoma 64 Roche Herceptin 64 microtubule inhibitor 64 mutated KRAS gene 64 skeletal metastases 64 aromatase inhibitor AI 64 antiangiogenic agents 64 hepatic metastases 64 rFVIIa 64 VNP#M 64 chemotherapeutic regimen 64 indibulin 64 relapsed CLL 64 IAP inhibitor 64 FASLODEX 64 recurrent malignant glioma 64 vemurafenib 64 mitoxantrone 64 EGFR TKI 64 nephrotoxicity 64 micafungin 64 angiogenesis inhibitor 64 Temozolomide 64 YONDELIS R 64 Abiraterone acetate 64 Allovectin 7 ® 64 doxorubicin Adriamycin 64 Trabectedin 64 calcineurin inhibitors 64 imatinib resistance 64 anti angiogenic agent 64 TKI therapy 64 nonalcoholic steatohepatitis NASH 64 5 fluorouracil leucovorin 64 Akt inhibitor 64 benign prostatic hypertrophy BPH 64 sargramostim 64 OPAXIO 64 Vincristine 64 H. pylori eradication 64 Everolimus 64 Pazopanib 64 interferon IFN 64 5-fluorouracil/leucovorin 64 IgG1 monoclonal antibody 64 Sutent sunitinib 64 darunavir r 64 CIMZIA TM certolizumab pegol 64 TMP SMX 64 cytoreductive nephrectomy 64 mycosis fungoides 64 fallopian tube cancers 64 obatoclax 64 tenofovir emtricitabine 64 Folotyn 64 EGFR TKIs 64 preoperative chemotherapy 64 bevacizumab Avastin Genentech 64 idraparinux 64 PSMA ADC 64 CBLC# 64 Panzem NCD 64 anti TNF 64 cisplatin 64 Alkeran 64 aspirin clopidogrel 64 pyridostigmine 64 chimeric monoclonal antibody 64 immunoconjugate 64 nucleotide analogue 64 DU #b 64 metastatic castrate resistant 64 anastrazole 64 myeloproliferative disorders 64 intra arterial chemotherapy 64 HGS# 64 proteasome inhibitors 64 Capecitabine 64 paclitaxel chemotherapy 64 transarterial 64 acyclovir Lauriad R 64 R sorafenib tablets 64 NMIBC 64 BRAF V# mutation 64 Squalamine 64 peritoneal cancer 64 Gliadel Wafer 64 CR# vcMMAE 64 efavirenz EFV 64 Vorinostat 64 Vaprisol 64 Mimpara 64 anti mitotic 64 INCB# [003] 64 prostate cancer mCRPC 64 colorectal cancer liver metastases 64 castration resistant prostate cancer 64 Oral corticosteroids 64 thromboembolic disease 64 PREZISTA r 64 efaproxiral 64 methotrexate therapy 64 relapsed refractory multiple myeloma 64 daunorubicin 64 oral Hycamtin 64 personalized immunotherapy 64 diabetic neuropathic pain 64 virotherapy 64 Amplimexon 64 thromboembolisms 64 atypical hemolytic uremic syndrome 64 Navelbine 64 SPRYCEL ® 64 erlotinib 64 thetreatment 64 denileukin diftitox 64 neoplasia 64 LHRH antagonists 64 entinostat 64 EGFR expressing mCRC 64 HER2 positive cancers 64 haematological cancers 64 G#DT 64 Yondelis ® 64 Fingolimod 64 ATL# [001] 64 myelofibrosis polycythemia vera 64 fludarabine 64 EndoTAG TM -1 64 endostatin 64 nitazoxanide 64 post menopausal osteoporosis 64 3TC lamivudine Epivir 64 ER CHOP 64 zidovudine AZT 64 Cancidas 64 fluvastatin 64 hydroxymethyl coenzyme 64 alpha 2a 64 unresectable tumors 64 trastuzumab Herceptin R 64 taxane 64 hypomethylating agents 64 Anastrozole 63 insulin sensitizing 63 HCV protease inhibitors 63 Decitabine 63 TG# [003] 63 Telintra 63 mutated K ras 63 Tacrolimus 63 carboplatin 63 vidofludimus 63 chemoradiation 63 Peginterferon 63 TNF alpha antagonist 63 Aptivus ® 63 PEG interferon 63 Gemzar gemcitabine 63 antiangiogenesis 63 CAELYX 63 Epirubicin 63 IV NSCLC 63 Afatinib 63 mCRC patients 63 TKIs 63 tumor subtypes 63 advanced metastatic renal 63 oropharyngeal candidiasis 63 Hedgehog inhibitor 63 Gemzar ® 63 malignant pleural mesothelioma MPM 63 PXD# 63 ceftazidime 63 cisplatin carboplatin 63 baminercept 63 HER2 positive 63 microtubule targeting 63 IRX 2 63 pemetrexed 63 alfa 2a 63 FOLFOX chemotherapy 63 CCR5 antagonist 63 nilotinib Tasigna ® 63 Imiquimod 63 CTAP# Capsules 63 subcutaneous formulation 63 radiochemotherapy 63 pancreatic adenocarcinoma 63 IAP inhibitors 63 EGFR tyrosine kinase inhibitor 63 systemic lupus erythematosus 63 viral kinetics 63 KRAS status 63 relapsed leukemia 63 stavudine d4T 63 LHRH agonist 63 nilotinib Tasigna 63 anthracyclines 63 post herpetic neuralgia PHN 63 inhibitor RG# 63 Eli Lilly Gemzar 63 antithrombotic 63 AVASTIN 63 histone deacetylase HDAC inhibitor 63 immune modulating 63 hormone refractory 63 transarterial chemoembolization 63 stage IIIB IV 63 Cremophor 63 lymphomas leukemias 63 ciclosporin 63 chemoresistance 63 castration resistant 63 Seliciclib 63 Jevtana 63 taxane resistant 63 Hycamtin ® 63 hormone deprivation 63 noscapine 63 CCR5 inhibitors 63 subcutaneously administered 63 somatostatin analogues 63 ABVD 63 dacetuzumab 63 refractory angina 63 RoACTEMRA 63 VEGF inhibitor 63 Imprime PGG 63 gefitinib 63 pan HDAC inhibitor 63 imatinib resistant 63 Mipomersen 63 protease inhibitors PIs 63 doublet chemotherapy 63 nonnucleoside reverse transcriptase inhibitors 63 immunosuppressant drug 63 indinavir 63 refractory NSCLC 63 Tykerb lapatinib 63 cidofovir 63 bleomycin 63 pegylated liposomal doxorubicin PLD 63 eflornithine 63 immunosuppressant 63 vascular disrupting agents 63 GIST tumors 63 Azedra 63 VIDAZA 63 sulfasalazine 63 targeted antifolate 63 nodal metastasis 63 antiarrhythmic 63 Raltegravir 63 neovascular diseases 63 AA Amyloidosis 63 epithelial tumors 63 EOquin TM 63 talabostat 63 ADP receptor antagonist 63 ximelagatran 63 prostate adenocarcinoma 63 trans retinoic acid ATRA 63 CLL SLL 63 selective modulator 63 tyrosine kinase inhibitors TKIs 63 dose cytarabine 63 sitaxsentan 63 NSCLC 63 Fluconazole 63 HBeAg negative 63 molecularly targeted 63 choroidal vasculopathy 63 somatostatin analogue 63 metastatic androgen independent 63 Hormonal therapy 63 acute leukemias 63 EFAPROXYN 63 investigational monoclonal antibody 63 Hsp# inhibition 63 low dose cytarabine 63 PD LID 63 antibody MAb 63 null responder 63 Sebivo 63 myelodysplastic myeloproliferative diseases 63 romidepsin 63 chemotherapy FOLFOX 63 generation purine nucleoside 63 lenalidomide Revlimid 63 factor TNF 63 abacavir Ziagen 63 busulfan 63 phase IIb clinical 63 T#I [002] 63 cardiotoxicity 63 Panzem 63 strontium ranelate 63 assessing T DM1 63 mesalazine 63 gp# vaccine 63 ON #.Na 63 chemosensitivity 63 antiretroviral naïve 63 anidulafungin 63 metastatic CRC 63 anthracycline containing 63 peginterferon alpha 2a 63 visilizumab 63 APTIVUS R 63 baseline LDH 63 DCVax ® Brain 63 hypercalcemia 63 oral ridaforolimus 63 Novartis Zometa 63 BCG refractory 63 Advagraf 63 IL# PE#QQR 63 Dalbavancin 63 fibrinolytic 63 Hormone Refractory Prostate Cancer 63 mycophenolate mofetil MMF 63 HERCEPTIN 63 monoclonal antibody therapies 63 refractory chronic lymphocytic 63 Xelox 63 MMP inhibitors 63 Candida infection 63 glufosfamide 63 Exemestane 63 mecamylamine 63 metastatic colorectal cancer 63 haematologic malignancies 63 sorafenib Nexavar R 63 tumor necrosis 63 KRAS mutation 63 HGS ETR2 63 comparator arm 63 Perifosine 63 signal transduction inhibitors 63 TASKi3 63 acute promyelocytic leukemia APL 63 dapsone 63 Procoralan 63 NNRTIs 63 APTIVUS 63 lumiliximab 63 Androgen deprivation therapy 63 IGF 1R inhibitor 63 chronic granulomatous disease 63 Nexavar tablets 63 Kinoid 63 dalteparin 63 Luteinizing Hormone Releasing Hormone 63 alefacept 63 Bevacizumab Avastin 63 eniluracil 63 ISF# 63 alpha interferons 63 liver metastasis 63 hematologic toxicity 63 GRASPA ® 63 diagnostic biomarker 63 Camptosar ® irinotecan 63 raloxifene Evista 63 LEP ETU 63 isoproterenol 63 hematopoietic cancers 63 Interferon beta 63 romiplostim 63 weekly subcutaneous injections 63 zoledronate 63 JAK2 inhibitor 63 Adjuvant therapy 63 Ataluren 63 TNF blocker therapy 63 histone deacetylase inhibitor 63 doxorubicin HCl 63 immunosuppressive therapies 63 myelodysplastic syndromes MDS 63 pamidronate 63 chronic GVHD 63 Triapine 63 advanced HER2 positive 63 tesmilifene 63 Allovectin 7 63 eosinophilic asthma 63 tacrolimus ointment 63 enfuvirtide 63 Reverset 63 induced anemia 63 oral prodrug 63 ganciclovir 63 Romiplostim 63 angiotensin receptor blocker ARB 63 cancer mCRC 63 refractory acute myeloid 63 antiangiogenic 63 cisplatin vinorelbine 63 ritonavir boosted lopinavir 63 IFN alfa 63 CEQ#